660 related articles for article (PubMed ID: 33787218)
1. Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry.
Perez-Miller S; Patek M; Moutal A; Duran P; Cabel CR; Thorne CA; Campos SK; Khanna R
ACS Chem Neurosci; 2021 Apr; 12(8):1299-1312. PubMed ID: 33787218
[TBL] [Abstract][Full Text] [Related]
2. In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein.
Perez-Miller S; Patek M; Moutal A; Cabel CR; Thorne CA; Campos SK; Khanna R
bioRxiv; 2020 Sep; ():. PubMed ID: 32995772
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 spike protein co-opts VEGF-A/neuropilin-1 receptor signaling to induce analgesia.
Moutal A; Martin LF; Boinon L; Gomez K; Ran D; Zhou Y; Stratton HJ; Cai S; Luo S; Gonzalez KB; Perez-Miller S; Patwardhan A; Ibrahim MM; Khanna R
Pain; 2021 Jan; 162(1):243-252. PubMed ID: 33009246
[TBL] [Abstract][Full Text] [Related]
4. Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1.
Hashizume M; Takashima A; Ono C; Okamoto T; Iwasaki M
Antiviral Res; 2023 Jan; 209():105481. PubMed ID: 36481388
[TBL] [Abstract][Full Text] [Related]
5. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
Sabki A; Khelifi L; Kameli A; Baali S
Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia.
Moutal A; Martin LF; Boinon L; Gomez K; Ran D; Zhou Y; Stratton HJ; Cai S; Luo S; Gonzalez KB; Perez-Miller S; Patwardhan A; Ibrahim MM; Khanna R
bioRxiv; 2020 Sep; ():. PubMed ID: 32869019
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1, and NRP-1 in human cells from the respiratory, urinary, digestive, reproductive, and immune systems.
Zhang F; Li W; Feng J; Ramos da Silva S; Ju E; Zhang H; Chang Y; Moore PS; Guo H; Gao SJ
J Med Virol; 2021 Dec; 93(12):6671-6685. PubMed ID: 34324210
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 in the pathogenesis of preeclampsia, HIV-1, and SARS-CoV-2 infection: A review.
Naidoo N; Moodley J; Khaliq OP; Naicker T
Virus Res; 2022 Oct; 319():198880. PubMed ID: 35905790
[TBL] [Abstract][Full Text] [Related]
9. Folic Acid and Leucovorin Have Potential to Prevent SARS-CoV-2-Virus Internalization by Interacting with S-Glycoprotein/Neuropilin-1 Receptor Complex.
Škrbić R; Travar M; Stojiljković MP; Djuric DM; Suručić R
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903540
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
Lavie M; Dubuisson J; Belouzard S
J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
[TBL] [Abstract][Full Text] [Related]
11. The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review.
Gudowska-Sawczuk M; Mroczko B
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202613
[TBL] [Abstract][Full Text] [Related]
12. The role of Neuropilin-1 in COVID-19.
Mayi BS; Leibowitz JA; Woods AT; Ammon KA; Liu AE; Raja A
PLoS Pathog; 2021 Jan; 17(1):e1009153. PubMed ID: 33395426
[TBL] [Abstract][Full Text] [Related]
13. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2.
Winstone H; Lista MJ; Reid AC; Bouton C; Pickering S; Galao RP; Kerridge C; Doores KJ; Swanson CM; Neil SJD
J Virol; 2021 Apr; 95(9):. PubMed ID: 33563656
[TBL] [Abstract][Full Text] [Related]
14. Host Manipulation Mechanisms of SARS-CoV-2.
Massey SE
Acta Biotheor; 2021 Dec; 70(1):4. PubMed ID: 34902063
[TBL] [Abstract][Full Text] [Related]
15. A widespread viral entry mechanism: The C-end Rule motif-neuropilin receptor interaction.
Balistreri G; Yamauchi Y; Teesalu T
Proc Natl Acad Sci U S A; 2021 Nov; 118(49):. PubMed ID: 34772761
[TBL] [Abstract][Full Text] [Related]
16. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.
Chapoval SP; Keegan AD
Mol Med; 2021 Dec; 27(1):162. PubMed ID: 34961486
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Fusion Process of SARS-CoV-2 Infection by Small Molecule Inhibitors.
Park SB; Irvin P; Hu Z; Khan M; Hu X; Zeng Q; Chen C; Xu M; Leek M; Zang R; Case JB; Zheng W; Ding S; Liang TJ
mBio; 2022 Feb; 13(1):e0323821. PubMed ID: 35012356
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-1 is a host factor for SARS-CoV-2 infection.
Daly JL; Simonetti B; Klein K; Chen KE; Williamson MK; Antón-Plágaro C; Shoemark DK; Simón-Gracia L; Bauer M; Hollandi R; Greber UF; Horvath P; Sessions RB; Helenius A; Hiscox JA; Teesalu T; Matthews DA; Davidson AD; Collins BM; Cullen PJ; Yamauchi Y
Science; 2020 Nov; 370(6518):861-865. PubMed ID: 33082294
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M
Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293
[TBL] [Abstract][Full Text] [Related]
20. Computational Screening of Neuropilin-1 Unveils Novel Potential Anti-SARS-CoV-2 Therapeutics.
Afiadenyo M; Adams L; Agoni C; Moane S; Mckeon-Bennett M; Obiri-Yeboah D; Singh J
Chem Biodivers; 2023 Dec; 20(12):e202301227. PubMed ID: 37878727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
